Ticker,Title,Link
RYTM,FDA sets target action date for Rhythm's sNDA for Imcivree,8/26/2024 4:38:14 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,8/13/2024 10:01:00 PM
RYTM,Wells Fargo Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM),8/12/2024 11:18:22 AM
RYTM,Morgan Stanley Sticks to Their Buy Rating for Rhythm Pharmaceuticals (RYTM),8/7/2024 12:58:43 PM
RYTM,Buy Rating Reaffirmed for Rhythm Pharmaceuticals Amid Strong Imcivree Sales and Promising Clinical Trials,8/6/2024 7:45:28 PM
RYTM,Rhythm Pharmaceuticals Q2 2024 Earnings Preview,8/5/2024 4:18:39 PM
RYTM,Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old,7/31/2024 3:10:21 PM
RYTM,A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 4 Analysts,7/25/2024 2:01:14 PM
RYTM,Buy Rating Affirmed for Rhythm Pharmaceuticals on Strong Drug Pipeline and Market Potential,7/24/2024 11:07:13 AM
RYTM,Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity,7/23/2024 2:00:00 PM
RYTM,Morgan Stanley Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM),7/12/2024 12:27:23 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,7/11/2024 10:01:00 PM
RYTM,"Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer",7/8/2024 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl...,6/28/2024 2:00:14 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,6/11/2024 10:01:00 PM
RYTM,"Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Corcept Therapeutics (CORT) and Rhythm Pharmaceuticals (RYTM)",6/5/2024 11:41:35 AM
RYTM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Rhythm Pharmaceuticals (RYTM) and Healthequity (HQY)",6/4/2024 2:20:45 AM
RYTM,Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024,6/3/2024 10:02:00 PM
RYTM,Goldman Sachs raises obesity drug market estimate to $130B,5/30/2024 3:22:06 PM
RYTM,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
RYTM,Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome,5/22/2024 10:00:00 AM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,5/9/2024 10:01:00 PM
RYTM,Maintaining Buy Rating on Rhythm Pharmaceuticals: Positive Outlook Amidst Growth and Upcoming Catalysts,5/8/2024 2:47:21 PM
RYTM,The 3 Best Nasdaq Stocks to Buy in May 2024,5/7/2024 6:52:31 PM
RYTM,Notable earnings before Tuesday's open,5/6/2024 3:08:27 PM
RYTM,Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology,4/30/2024 12:30:00 AM
RYTM,Analyst Expectations For Rhythm Pharmaceuticals's Future,4/26/2024 3:01:18 PM
RYTM,"Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024",4/24/2024 10:01:00 PM
RYTM,Wells Fargo Remains a Buy on Rhythm Pharmaceuticals (RYTM),4/18/2024 10:45:56 AM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,4/16/2024 10:01:00 PM
RYTM,5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know,4/10/2024 6:00:50 PM
RYTM,"Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst",4/7/2024 12:00:00 PM
RYTM,Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing,4/1/2024 2:00:00 PM
RYTM,Viking Therapeutics gains on early data for oral weight loss therapy,3/26/2024 11:37:54 AM
RYTM,"Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist",3/25/2024 1:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,3/11/2024 9:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences,3/6/2024 10:01:00 PM
RYTM,Rhythm Pharmaceuticals: Expanding Markets and Innovation Fuel Buy Rating Upgrade,2/23/2024 1:26:41 PM
RYTM,Buy Rating Affirmed for Rhythm Pharmaceuticals Amid Strong Imcivree Performance and Market Expansion,2/22/2024 7:25:16 PM
RYTM,Rhythm Pharmaceuticals Q4 2023 Earnings Preview,2/21/2024 4:01:15 PM
RYTM,Stifel Nicolaus Reaffirms Their Buy Rating on Rhythm Pharmaceuticals (RYTM),2/9/2024 1:28:45 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,2/8/2024 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome,2/7/2024 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024",1/31/2024 2:00:00 PM
RYTM,Buy Rating Reaffirmed for Rhythm Pharmaceuticals Amid Stable Sales Projections and Strong Product Outlook,1/26/2024 10:55:36 AM
RYTM,Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (7 Ratings),1/25/2024 6:00:46 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,1/12/2024 10:01:00 PM
RYTM,"Analysts Are Bullish on Top Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Phathom Pharmaceuticals (PHAT)",1/5/2024 11:50:11 AM
RYTM,The Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Experts,1/4/2024 5:00:58 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,12/15/2023 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Sponsors Second Annual International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE) 2023,12/13/2023 1:00:00 PM
RYTM,"Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Regeneron (REGN) and PAVmed (PAVM)",12/8/2023 12:50:25 PM
RYTM,Analyst Expectations for Rhythm Pharmaceuticals's Future,12/7/2023 4:00:12 PM
RYTM,Rhythm Pharmaceuticals: A Strong Buy on Imcivree’s Promise and RM-718’s Market Potential,12/6/2023 7:55:22 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,11/13/2023 10:01:00 PM
RYTM,Rhythm Pharmaceuticals: Financial Stability and Growth Prospects Justify Buy Rating,11/8/2023 12:40:59 PM
RYTM,"Rhythm Pharmaceuticals: Strong Q3 Results, Expanding International Presence and Potential Undervaluation Support Buy Recommendation",11/7/2023 8:15:36 PM
RYTM,Here's what to expect from Rhythm Pharmaceuticals's earnings,11/6/2023 3:01:14 PM
RYTM,Rhythm Pharmaceuticals Receives Positive CADTH Reimbursement Recommendation for IMCIVREE® (setmelanotide),11/2/2023 1:00:00 PM
RYTM,Setmelanotide’s Promising Results and Expanding Market Potential Drive Analyst’s Buy Rating on Rhythm Pharmaceuticals,10/30/2023 11:26:04 AM
RYTM,"Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023",10/25/2023 2:00:00 PM
RYTM,"3 Best Stocks to Buy Now, 10/20/2023, According to Top Analysts",10/20/2023 11:25:51 AM
RYTM,Optimistic Market Potential for Rhythm Pharmaceuticals’ Imcivree Drives Buy Rating,10/19/2023 10:47:09 AM
RYTM,Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Rhythm Pharmaceuticals (RYTM),10/18/2023 5:40:24 PM
RYTM,Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at...,10/17/2023 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,10/13/2023 10:01:00 PM
RYTM,Morgan Stanley Maintains Equal-Weight Rating for Rhythm Pharmaceuticals: Here's What You Need To Know,10/10/2023 7:00:22 PM
RYTM,Rhythm Pharmaceuticals Presents New Data at ESPE 2023,9/22/2023 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Receives Orphan Drug Designation from European Medicines Agency for Setmelanotide for Treatment of Acquired Hypothalamic Obesity,9/19/2023 2:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,9/8/2023 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome,9/6/2023 1:59:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Investor Conferences in September,8/28/2023 2:00:00 PM
RYTM,Nearly half of U.S. adults want weight-loss drugs – KFF poll,8/6/2023 4:00:54 PM
RYTM,"Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023",8/2/2023 5:00:31 PM
RYTM,Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,8/1/2023 9:05:37 PM
RYTM,Rhythm Pharmaceuticals Q2 2023 Earnings Preview,7/31/2023 6:51:15 PM
RYTM,"These 2 Biotech Stocks Are Most Likely to Be Acquired, Says Needham — and They Have Over 60% Upside Potential",7/14/2023 8:40:34 PM
RYTM,"Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), COMPASS Pathways (CMPS)",6/20/2023 12:30:15 PM
RYTM,Morgan Stanley sees broader MedTech impact from weight loss drugs,6/4/2023 4:00:08 PM
RYTM,Rhythm Pharma wins Canadian nod for weight loss therapy,5/8/2023 12:53:22 PM
RYTM,Spending on weight loss drugs to rise 378% in 2023 – 2027: report,5/7/2023 4:00:27 PM
RYTM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Sarepta Therapeutics (SRPT) and Rhythm Pharmaceuticals (RYTM)",5/3/2023 11:01:56 AM
RYTM,Goldman Sachs Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM),5/2/2023 4:55:06 PM
RYTM,Rhythm Pharmaceuticals is about to announce earnings — here's what Wall Street expects,5/1/2023 3:01:13 PM
RYTM,Lilly obesity therapy shows ~16% weight loss in Phase 3 trial,4/27/2023 10:55:09 AM
RYTM,"PACW, FGEN and OVID are among after hour movers",4/24/2023 9:17:27 PM
RYTM,Needham Remains a Buy on Rhythm Pharmaceuticals (RYTM),4/18/2023 12:39:18 PM
RYTM,Pfizer CEO Albert Bourla backs FDA after abortion pill ruling,4/10/2023 2:48:10 PM
RYTM,WHO to weigh adding obesity therapies to 'essential' medicines list – Reuters,3/29/2023 2:50:46 PM
RYTM,Altimmune leads obesity drug developers lower after data for lead asset,3/21/2023 6:58:24 PM
RYTM,New weight loss therapies can burden Medicare - experts,3/12/2023 5:00:16 PM
RYTM,Rhythm Pharma has ~$3.4M in deposits with SVB Financial,3/10/2023 8:07:43 PM
RYTM,Expert Ratings for Rhythm Pharmaceuticals,3/2/2023 4:01:13 PM
RYTM,Rhythm Pharmaceuticals beats Q4 top and bottom line estimates; initiates FY23 outlook,3/1/2023 12:08:03 PM
RYTM,Rhythm Pharmaceuticals Q4 2022 Earnings Preview,2/28/2023 5:41:54 PM
RYTM,Rhythm Pharma acquires rare disease company Xinvento,2/27/2023 2:29:14 PM
RYTM,Looking for Powerful Healthcare Stocks? These 5 Made Enormous Profit in 2022,2/17/2023 6:25:51 AM
RYTM,Canaccord loves these biotech stocks — and gives them upside of more than 80%,2/3/2023 7:51:31 PM
RYTM,Rhythm Pharma announces positive data from phase 3 trial of obesity treatment,1/23/2023 1:50:26 PM
RYTM,Rhythm Pharmaceuticals Announces ▼IMCIVREE® (setmelanotide) Granted Marketing Authorization in Great Britain for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome ,11/21/2022 2:00:00 PM
RYTM,Morgan Stanley Keeps Their Hold Rating on Rhythm Pharmaceuticals (RYTM),11/9/2022 4:35:49 PM
RYTM,Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trial of IMCIVREE® (setmelanotide) in Bardet-Biedl Syndrome in The Lancet Diabetes and Endocrinology,11/8/2022 1:05:00 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,11/7/2022 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces 11 Presentations at The Obesity Society’s Annual Meeting at ObesityWeek®,11/3/2022 1:00:00 PM
RYTM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), G1 Therapeutics (GTHX) and Rhythm Pharmaceuticals (RYTM)",11/2/2022 4:20:43 PM
RYTM,Rhythm Pharmaceuticals Announces Setmelanotide Granted Breakthrough Therapy Designation for Hypothalamic Obesity by the U.S. FDA,11/1/2022 1:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present Full Data from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity at ObesityWeek® 2022,10/25/2022 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Convenes Inaugural International Meeting on Pathway-Related Obesity: Vision of Excellence (IMPROVE) 2022,10/12/2022 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals Appoints Dana Washburn, M.D., as Senior Vice President of Clinical Development",10/6/2022 10:02:00 PM
RYTM,COVID stocks lag U.S. biopharma in Q3; Alzheimer’s theme regains focus,10/2/2022 4:00:31 PM
RYTM,Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS),9/23/2022 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Closing of $124.8 Million Public Offering",9/19/2022 10:01:00 PM
RYTM,Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday,9/16/2022 10:38:59 AM
RYTM,"Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session",9/15/2022 7:03:40 PM
RYTM,After-Hours Alert: Why Rhythm Pharmaceuticals Stock Is Diving,9/14/2022 10:33:03 PM
RYTM,Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday,9/13/2022 11:15:00 AM
RYTM,Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday,9/9/2022 10:14:31 AM
RYTM,Expert Ratings for Rhythm Pharmaceuticals,9/8/2022 7:11:47 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,9/7/2022 10:01:00 PM
RYTM,Rhythm Secures European Commission Marketing Authorization For Genetic Disease Candidate,9/6/2022 11:11:04 PM
RYTM,Rhythm Pharmaceuticals to Present at Investor Conferences in September,9/1/2022 2:00:00 PM
RYTM,Jim Cramer Says He's Passing On This $10 Social Media Stock As It's 'Losing Money',8/25/2022 2:40:47 PM
RYTM,This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday,8/16/2022 9:28:46 AM
RYTM,"Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session",8/15/2022 6:05:33 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,8/8/2022 10:01:00 PM
RYTM,"Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022",8/5/2022 4:43:02 PM
RYTM,This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday,8/4/2022 11:54:33 AM
RYTM,What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals,8/3/2022 7:22:26 PM
RYTM,Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition,8/2/2022 7:46:18 PM
RYTM,Rhythm Pharmaceuticals Q2 2022 Earnings Preview,8/1/2022 5:27:45 PM
RYTM,"Rhythm Pharmaceuticals to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022",7/28/2022 2:00:00 PM
RYTM,Recap Of Friday's Biotech Catalysts - End Of The Day Summary,7/22/2022 11:59:12 PM
RYTM,Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday,7/21/2022 10:40:37 AM
RYTM,Recap of Wednesday's Biotech Catalysts - End of The Day Summary,7/20/2022 11:59:56 PM
RYTM,Recap of Monday's Biotech Catalysts - End of the Day Summary,7/19/2022 12:07:45 AM
RYTM,"Inotiv, IO Biotech top healthcare gainers; Regulus, Aerovate lead losers' pack",7/18/2022 2:04:06 PM
RYTM,"Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday",7/14/2022 11:58:13 AM
RYTM,Rhythm Pharma extends gains to reach three-month high,7/13/2022 6:51:39 PM
RYTM,Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher,7/12/2022 8:39:08 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,7/8/2022 3:00:00 PM
RYTM,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,7/1/2022 11:26:23 AM
RYTM,Rhythm Pharma launches Imcivree in Germany to treat obesity caused by deficiencies,6/22/2022 3:21:06 PM
RYTM,33 Stocks Moving In Friday's Mid-Day Session,6/17/2022 6:12:45 PM
RYTM,Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 Million,6/16/2022 10:02:00 PM
RYTM,"ARWR, GDRX and ESPR among after hour movers.",6/15/2022 9:24:08 PM
RYTM,"Gelesis, Entrada top healthcare gainers; Outset Medical, Arcellx lead losers' pack",6/14/2022 2:04:44 PM
RYTM,70 Stocks Moving In Monday's Mid-Day Session,6/13/2022 6:10:43 PM
RYTM,6 Biotech Stocks to Buy Now Ahead of These June Catalysts,6/3/2022 9:11:37 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,6/2/2022 10:01:00 PM
RYTM,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,5/31/2022 9:42:54 PM
RYTM,Biotech Stocks Facing FDA Decision In June 2022 ,5/27/2022 4:04:02 PM
RYTM,Expert Ratings for Rhythm Pharmaceuticals,5/24/2022 6:15:30 PM
RYTM,3 Stocks to Buy the Dip Now,5/20/2022 8:58:52 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,5/5/2022 10:01:00 PM
RYTM,Rhythm Pharmaceuticals to Present at BofA Securities 2022 Healthcare Conference,5/4/2022 2:00:00 PM
RYTM,"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",5/3/2022 3:01:06 PM
RYTM,Rhythm Pharmaceuticals Q1 2022 Earnings Preview,5/2/2022 4:49:32 PM
RYTM,"Rhythm Pharmaceuticals to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022",4/26/2022 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,4/8/2022 2:00:00 PM
RYTM,51 Biggest Movers From Yesterday,4/7/2022 10:37:24 AM
RYTM,40 Stocks Moving In Wednesday's Mid-Day Session,4/6/2022 7:19:51 PM
RYTM,Expert Ratings For Rhythm Pharmaceuticals,3/7/2022 3:28:50 PM
RYTM,Rhythm Pharmaceuticals to Present at Cowen & Co. 42nd Annual Health Care Conference,3/1/2022 10:01:00 PM
RYTM,"Thinking About Buying Stock In Lucid Group, Rhythm Pharmaceuticals Or Kohl's?",2/28/2022 9:21:37 PM
RYTM,Why Rhythm Pharmaceuticals Shares Are Falling Today,2/24/2022 8:06:03 PM
RYTM,Rhythm Pharmaceuticals Announces Promotions within its Executive Leadership Team,2/23/2022 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 1, 2022",2/22/2022 2:00:00 PM
RYTM,60 Biggest Movers From Yesterday,2/18/2022 10:42:09 AM
RYTM,"Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022",2/17/2022 4:02:21 PM
RYTM,Rhythm Pharma's Highlights Interim Setmelanotide Data In Long Term Genetic Disorder Trial,2/16/2022 5:07:03 PM
RYTM,Rhythm Pharmaceuticals to Host Virtual Bardet-Biedl Syndrome (BBS) Event on February 16,2/8/2022 10:00:00 PM
RYTM,"Lawson Products, Houghton Mifflin Harcourt lead postmarket gainers; Rhythm Pharma top loser",1/14/2022 10:04:41 PM
RYTM,Rhythm Pharmaceuticals Announces First Patients Dosed in DAYBREAK and Weekly Trials Evaluating Setmelanotide for Rare Genetic Diseases of Obesity,1/13/2022 3:15:00 PM
RYTM,"Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021",12/8/2021 4:04:34 PM
RYTM,Rhythm Pharma inks licensing deal for development of Imcivree in China,12/6/2021 2:19:31 PM
RYTM,"Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021",11/19/2021 4:08:55 PM
RYTM,Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström...,11/15/2021 1:45:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Stifel 2021 Virtual Healthcare Conference,11/9/2021 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results,11/2/2021 12:00:00 PM
RYTM,Rhythm Pharmaceuticals Presents First-ever Data Showing Improvements in Health-related Quality of Life for Patients Living with Bardet-Biedl Syndrome at ObesityWeek® 2021,11/1/2021 9:01:00 PM
RYTM,"Rhythm Pharmaceuticals to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021",10/20/2021 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes,10/14/2021 10:01:00 PM
RYTM,"The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology",10/12/2021 2:13:34 PM
RYTM,"Rhythm Pharma's Imcivree Wins UK Approval For Obesity, Hunger Control",9/22/2021 6:23:02 PM
RYTM,Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE® (setmelanotide) for the treatment of obesity and control of...,9/20/2021 1:30:00 PM
RYTM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",9/9/2021 2:17:07 PM
RYTM,Rhythm Pharmaceuticals Announces Expanded Access Program for Setmelanotide for Patients with Bardet-Biedl Syndrome,9/8/2021 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces CMO Transition,9/2/2021 10:01:00 PM
RYTM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",8/20/2021 1:45:43 PM
RYTM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",8/18/2021 1:37:56 PM
RYTM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",8/17/2021 2:28:53 PM
RYTM,Rhythm Pharmaceuticals to Present at the 59th Annual ESPE Meeting,8/12/2021 1:45:00 PM
RYTM,"The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO",8/6/2021 1:42:39 PM
RYTM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",8/5/2021 2:07:56 PM
RYTM,58 Stocks Moving In Wednesday's Mid-Day Session,8/4/2021 6:09:35 PM
RYTM,"The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business",8/3/2021 1:55:12 PM
RYTM,"The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs",8/1/2021 4:13:48 PM
RYTM,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",7/29/2021 2:18:48 PM
RYTM,Rhythm Pharmaceuticals Announces Collaborative Research Agreement with Clinical Registry Investigating Bardet-Biedl Syndrome,7/28/2021 10:01:00 PM
RYTM,"Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021",7/27/2021 2:00:00 PM
RYTM,"Rhythm Pharma's Imcivree Gets European Approval For Obesity, Control of Hunger Associated With Genetic Mutations",7/23/2021 4:17:00 PM
RYTM,Rhythm Pharmaceuticals and Medison Pharma Partner to Commercialize IMCIVREE™ (setmelanotide) in Israel ,7/22/2021 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference,5/27/2021 2:00:00 PM
RYTM,Rhythm Pharma Receives Positive CHMP Opinion For Setmelanotide - Quick Facts ,5/21/2021 2:59:04 PM
RYTM,Rhythm Pharmaceuticals to Present at BofA Securities 2021 Virtual Health Care Conference,5/5/2021 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results,5/3/2021 2:00:00 PM
RYTM,7 Beaten Down Stocks with Significant Insider Buying,4/9/2021 6:16:10 PM
RYTM,Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference,4/7/2021 2:00:00 PM
RYTM,"The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract",4/1/2021 1:46:30 PM
RYTM,"GTAT, PFIN, DISCB and BCEL among after-hours movers",3/31/2021 9:56:17 PM
RYTM,Rhythm posts promising obesity study results at ENDO 2021,3/22/2021 9:56:38 AM
RYTM,Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021,3/20/2021 4:30:00 PM
RYTM,Seeking Alpha Catalyst Watch,3/19/2021 7:30:46 PM
RYTM,"Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations",3/14/2021 1:14:58 PM
RYTM,Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ENDO 2021,3/9/2021 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results,3/1/2021 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference,2/24/2021 2:30:00 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares",2/10/2021 11:23:37 PM
RYTM,"PTON ,U among premarket losers",2/5/2021 1:34:17 PM
RYTM,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",2/4/2021 1:21:58 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering",2/3/2021 10:01:00 PM
RYTM,"BBBY, RDHL, TTOO and OPCH among after-hours movers",1/27/2021 10:47:38 PM
RYTM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",1/26/2021 2:07:40 PM
RYTM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",1/23/2021 3:14:04 PM
RYTM,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",1/22/2021 1:22:34 PM
RYTM,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",1/21/2021 2:05:24 PM
RYTM,Rhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts,1/19/2021 2:00:00 PM
RYTM,"The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs",1/8/2021 1:25:06 PM
RYTM,"MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301 ",1/6/2021 7:58:20 AM
RYTM,Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M,1/5/2021 2:16:45 PM
RYTM,Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes,12/22/2020 1:00:00 PM
RYTM,"Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors",12/11/2020 2:15:00 PM
RYTM,"RIOT, NVAX, MARA and SOL among midday movers",11/27/2020 4:23:33 PM
RYTM,"Week Ahead In Pharma: EIGR Scripts History With Progeria Treatment, LQDA, RYTM Await FDA Decision ",11/22/2020 6:13:07 AM
RYTM,Seeking Alpha Catalyst Watch,11/20/2020 8:30:48 PM
RYTM,Rhythm Pharmaceuticals Announces New Clinical Data on Setmelanotide at ObesityWeek® 2020,11/4/2020 10:30:00 PM
RYTM,Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results,11/2/2020 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology,10/31/2020 12:30:00 AM
RYTM,"Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America",10/28/2020 1:00:10 PM
RYTM,Biotech Stocks Facing FDA Decision In November 2020 ,10/26/2020 6:45:58 AM
RYTM,"Rhythm Pharmaceuticals Appoints Yann Mazabraud as Executive Vice President, Head of International",9/14/2020 10:01:10 PM
RYTM,Rhythm Pharmaceuticals to Present at Investor Conferences in September,9/9/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference,8/6/2020 2:00:10 PM
RYTM,"ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. ",8/4/2020 9:31:42 AM
RYTM,Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results,8/3/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Announces Appointment of Joseph Shulman as Senior Vice President of Technical Operations,7/27/2020 2:00:10 PM
RYTM,"Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer",7/20/2020 1:30:10 PM
RYTM,"Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide in Bardet-Biedl Syndrome in Diabetes, Obesity and Metabolism",7/16/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Setmelanotide for Treatment of POMC and LEPR Deficiency Obesities,7/1/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers,6/24/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conference in June,5/26/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Announces FDA Acceptance of New Drug Application for Setmelanotide for the Treatment of POMC and LEPR Deficiency Obesities,5/13/2020 3:00:10 PM
RYTM,Rhythm Pharmaceuticals to Present Virtually at 2020 BofA Securities Health Care Conference,5/5/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Reports First Quarter 2020 Financial Results,5/4/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals to Present Virtually at Needham & Co. 19th Annual Healthcare Conference,4/7/2020 2:00:10 PM
RYTM,Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations,3/30/2020 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for Setmelanotide for the Treatment of Alström Syndrome,3/18/2020 1:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results,3/2/2020 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference,2/25/2020 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Leadership Transition,1/6/2020 10:15:00 PM
RYTM,Rhythm Pharmaceuticals Completes Enrollment of Pivotal Cohort in Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes,12/5/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Stifel 2019 Healthcare Conference,11/13/2019 2:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019,11/4/2019 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results,11/1/2019 1:31:46 PM
RYTM,Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ObesityWeek® 2019,10/30/2019 9:01:05 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares",10/18/2019 6:32:13 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering",10/16/2019 5:01:11 AM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering",10/15/2019 10:18:05 PM
RYTM,Rhythm Pharmaceuticals Provides Update on Research and Development Programs,9/25/2019 1:00:00 PM
RYTM,"Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV…) ",9/21/2019 1:03:07 PM
RYTM,Rhythm Pharmaceuticals to Provide an Update on Genetic Sequencing Efforts and Expansion of Phase 2 Basket Study with Four Additional Rare MC4R Pathway-driven Disorders ,9/9/2019 1:30:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September,9/3/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities,8/7/2019 1:01:00 PM
RYTM,Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results,7/29/2019 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors,7/24/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity,7/17/2019 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors,6/19/2019 10:01:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference,5/30/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference,5/7/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results,5/3/2019 2:36:03 PM
RYTM,Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference,4/2/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development,3/28/2019 12:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results,3/8/2019 2:12:31 PM
RYTM,Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference,3/4/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference,1/4/2019 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes,12/13/2018 1:00:00 PM
RYTM,"Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome",12/6/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018,11/15/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results,11/9/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference,11/7/2018 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer",10/15/2018 2:00:00 PM
RYTM,This Day That Year: Rhythm Pharma ,10/5/2018 6:36:21 AM
RYTM,Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome at 57th Annual ESPE Meeting,9/28/2018 1:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference,9/25/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference,9/7/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results,8/8/2018 10:01:00 PM
RYTM,Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity-- Program Offers Enhanced Support for Development of Medicines...,7/23/2018 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares",6/25/2018 10:01:00 PM
RYTM,"XBIO Turns Heads, HRTX Hits New High, RYTM In Good Rhythm, SBOT On Watch ",6/22/2018 3:05:32 AM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering",6/21/2018 3:37:51 AM
RYTM,"CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today ",6/19/2018 7:52:08 AM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering",6/18/2018 11:19:45 PM
RYTM,Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of ObesityOne-Year Data from Cohorts of 10 Enrolled...,6/14/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference,6/1/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results,5/14/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity,5/9/2018 10:01:00 PM
RYTM,"RSLS Deflated, ALKS Depressed, ALNY On Watch ",4/3/2018 6:22:31 AM
RYTM,Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome,4/2/2018 2:00:00 PM
RYTM,"Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018- Late-breaking data suggest there are potentially more than 12,000 people in the U.",3/19/2018 9:01:00 PM
RYTM,"FDA Places Clinical Hold On ADXS Study, ALT Proves A Good Shot, RYTM On Track ",3/13/2018 8:15:03 AM
RYTM,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results,3/12/2018 9:01:00 PM
RYTM,Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March,3/7/2018 10:01:00 PM
RYTM,WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity,1/9/2018 3:00:00 PM
RYTM,Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity,1/4/2018 2:00:00 PM
RYTM,Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results,11/14/2017 2:00:00 PM
RYTM,Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome,10/31/2017 1:01:00 PM
RYTM,"HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL ",10/17/2017 3:48:40 AM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares",10/10/2017 10:01:00 PM
RYTM,"Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering",10/5/2017 3:09:00 AM
